For this, we used logistic regression analysis to analyze the ability of CTCs in combination with serum CEA in predicting NSCLC aggressiveness, including TNM staging (I-IIIA and IIIB- IV), Ki-67 level, and tumor grade. This evidence concerns the gene MKI67 and neoplasm.